Product image of Mucotosse (Ambroxol Hydrochloride) supplied by GNH India

Mucotosse

Active Ingredient:
Ambroxol Hydrochloride
Origin:
EU

Mucotosse (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucotosse, is a mucolytic presented as an oral formulation for oral use. It helps reduce the thickness of respiratory secretions and facilitates expectoration in patients with coughs characterized by thick or viscous sputum, bronchitis, COPD, and upper respiratory tract infections.

GNH India supplies Mucotosse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions.

Manufacturer / TM Owner

Labialfarma - Laboratório De Produtos Farmacêuticos E Nutracêuticos, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ambroxol Hydrochloride is a mucolytic that acts on respiratory secretions to improve clearance.
  • Cough with thick or viscous sputum: Improves expectoration by reducing mucus viscosity.
  • Bronchitis: Facilitates mucus clearance, easing productive cough.
  • Chronic obstructive pulmonary disease (COPD): Assists in thinning secretions to aid breathing.
  • Upper respiratory tract infections: Helps relieve congestion by loosening airway mucus.

How It Works

  • Ambroxol Hydrochloride stimulates surfactant production in the respiratory tract and reduces the viscosity of mucus by disrupting mucopolysaccharide networks. This action enhances mucociliary transport, allowing cilia to move mucus more efficiently toward the pharynx, where it can be expectorated or swallowed, thereby improving airway patency and reducing cough severity.

Side Effects

Ambroxol Hydrochloride is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects

  • Taste alteration: A transient bitter or salty taste.
  • Nausea: Mild to moderate discomfort in the stomach.
  • Diarrhea: Loose stools occurring occasionally.
  • Abdominal discomfort: Cramping or mild pain.
  • Skin rash: Minor erythematous eruptions.

Serious or Rare Side Effects

  • Allergic reactions: Hives, swelling, or anaphylaxis.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic dysfunction: Elevated liver enzymes or jaundice.
  • Eosinophilia: Unexplained increase in eosinophil count.
  • Respiratory distress: Rare bronchospasm or worsening dyspnea.

Precautions & Warnings

  • When prescribing Ambroxol Hydrochloride, consider the following safety measures.
  • Pregnancy: Safety not established; use only if clearly needed.
  • Breastfeeding: Unknown excretion; weigh benefits against potential risks.
  • Renal impairment: Adjust use and monitor renal function.
  • Asthma: Observe for possible bronchospasm.
  • Drug interactions: Review concomitant medications for potential effects.
  • Store at ambient temperature below 25°C: Keep in the original pack, protect from moisture.

Avoid Interactions

Ambroxol Hydrochloride may interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors: May increase ambroxol plasma levels.
  • Cytotoxic chemotherapy agents: Potentially heightened pulmonary toxicity.
  • Anticholinergic drugs: May diminish mucociliary clearance benefits.

Moderate Interactions (Monitor Closely)

  • Antihistamines: Possible reduction in cough‑suppressant effect.
  • Beta‑blockers: Watch for respiratory status changes.
  • Alcohol: May exacerbate gastrointestinal irritation.

Frequently Asked Questions

Mucotosse contains ambroxol hydrochloride, a mucolytic indicated for the relief of coughs associated with thick or viscous sputum, bronchitis, chronic obstructive pulmonary disease (COPD) and upper respiratory tract infections. It works by thinning mucus, making it easier to clear from the airways.

Ambroxol hydrochloride stimulates the production of surfactant in the respiratory tract and reduces mucus viscosity by disrupting mucopolysaccharide structures. This enhances mucociliary transport, allowing cilia to move mucus toward the throat where it can be expectorated, thereby improving airway clearance.

The appropriate dose of Mucotosse is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and overall health status. Patients should follow the prescriber’s instructions and not alter the dosage without medical advice.

Safety data for ambroxol hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To order Mucotosse, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mucotosse’s active ingredient, ambroxol, directly stimulates surfactant production and reduces mucus viscosity, whereas some other expectorants act primarily by increasing airway secretions. Ambroxol’s dual action often results in more efficient clearance of thick mucus, especially in chronic respiratory conditions.

Mucotosse should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency.

Mucotosse is taken orally as directed by the prescriber. The tablet or liquid is swallowed with water, typically after meals, unless otherwise advised. Proper administration ensures optimal absorption and effectiveness.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, hepatic dysfunction, and eosinophilia. Patients should seek immediate medical attention if they experience rash, swelling, difficulty breathing, or signs of liver injury.

Mucotosse is contraindicated in individuals with known hypersensitivity to ambroxol or any excipients in the formulation. Caution is advised for patients with severe renal impairment, uncontrolled asthma, or those taking medications that may interact significantly with ambroxol.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ambroxol Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT